Literature DB >> 12065354

Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung.

Marc Licker1, Anastase Spiliopoulos, Jean-Georges Frey, John Robert, Laurent Höhn, Marc de Perrot, Jean-Marie Tschopp.   

Abstract

STUDY
OBJECTIVES: To assess the mortality rate and the incidence of cardiopulmonary complications after pneumonectomy for non-small cell lung carcinoma (NSCLC) and to identify possible associated risk factors.
DESIGN: Observational study of patients who underwent pneumonectomy. Potential risk factors were analyzed from a local database including all thoracic surgical cases.
SETTING: A university hospital and a chest medical center. PATIENTS AND METHODS: From January 1, 1990, to April 30, 2000, 193 consecutive pneumonectomies were performed for NSCLC in two affiliated institutions. The following information was recorded: demographic, clinical, functional, and surgical variables; as well as intraoperative and postoperative events. The risk of mortality and cardiopulmonary complications was evaluated using multiple logistic regression analysis to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: After undergoing pneumonectomy, all patients were successfully extubated in the operating room and then transferred to a postanesthesia care unit (126 patients) or ICU (67 patients). The 30-day mortality rate was 9.3%, and cardiovascular and/or pulmonary complications occurred in 47% of cases. Coronary artery disease (CAD) was a predictor of 30-day mortality (OR, 2.9; 95% CI, 1.1 to 8.9). Cardiac morbidity (mainly arrhythmias) was significantly related to advanced age (OR, 3.7; 95% CI, 1.6 to 8.6) and pathologic stages III/IV (OR, 1.4; 95% CI, 1.1 to 4.7), whereas continuous epidural analgesia was associated with a reduced incidence of respiratory complications (OR, 0.2; 95% CI, 0.1 to 0.6).
CONCLUSIONS: Pneumonectomy for lung cancer is a high-risk procedure, the risk for which is significantly related to the presence of CAD and advanced pathologic stages. Importantly, the provision of epidural analgesia contributes to lower the risk of respiratory complications.

Entities:  

Mesh:

Year:  2002        PMID: 12065354     DOI: 10.1378/chest.121.6.1890

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

1.  Paravertebral block via the surgical field versus epidural block for patients undergoing thoracotomy: a randomized clinical trial.

Authors:  Rei Kobayashi; Shoichi Mori; Kenji Wakai; Koichi Fukumoto; Takuya Saito; Tatsuya Katayama; Junya Nakata; Takayuki Fukui; Simon Ito; Tetsuya Abe; Shunzo Hatooka; Renko Hosoda; Tetsuya Mitsudomi
Journal:  Surg Today       Date:  2013-05-24       Impact factor: 2.549

Review 2.  [Consequences of pneumonectomy in the early and late phases].

Authors:  R A Hatz; L V Klotz
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

3.  Pneumonectomy for non-small cell lung cancer.

Authors:  Yoshinobu Ichiki; Akira Nagashima; Yasuhiro Chikaishi; Manabu Yasuda
Journal:  Surg Today       Date:  2012-04-07       Impact factor: 2.549

4.  The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer.

Authors:  Tomoyoshi Takenaka; Masakazu Katsura; Yasunori Shikada; Syuichi Tsukamoto; Sadanori Takeo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05

5.  Pneumonectomy for node-positive non-small cell lung cancer: can it be a treatment option for N2 disease?

Authors:  Satona Tanaka; Minoru Aoki; Hiroyuki Ishikawa; Yosuke Otake
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-03-01

6.  Tumour characteristics and therapeutic results after percutaneous radiofrequency ablation of secondary lung neoplasms.

Authors:  Didier Dequanter; Philippe Lothaire
Journal:  Clin Transl Oncol       Date:  2009-06       Impact factor: 3.405

7.  Safety of the paravertebral block in patients ineligible for epidural block undergoing pulmonary resection.

Authors:  Tatsuya Katayama; Shinji Hirai; Rei Kobayashi; Makoto Hamaishi; Takeshi Okada; Norimasa Mitsui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-16

Review 8.  Surgical strategies in the therapy of non-small cell lung cancer.

Authors:  Feras Al-Shahrabani; Daniel Vallböhmer; Sebastian Angenendt; Wolfram T Knoefel
Journal:  World J Clin Oncol       Date:  2014-10-10

9.  Surgical site infections after lung resection: a prospective study of risk factors in 1,091 consecutive patients.

Authors:  Andrea Imperatori; Elisa Nardecchia; Lorenzo Dominioni; Daniele Sambucci; Sebastiano Spampatti; Giancarlo Feliciotti; Nicola Rotolo
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

10.  UK pneumonectomy outcome study (UKPOS): a prospective observational study of pneumonectomy outcome.

Authors:  Ellie S Powell; Adrian C Pearce; David Cook; Paul Davies; Ehab Bishay; Geoffrey M R Bowler; Fang Gao
Journal:  J Cardiothorac Surg       Date:  2009-07-30       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.